A predictive model for identification of pediatric individuals with common variable immunodeficiency through

Nouf Alsaati1, Chris Penney2, Ingo Helbig3

  • 1Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.

Insights

Machine learning identified key indicators for early Common Variable Immunodeficiency (CVID) diagnosis in children. This approach can significantly reduce diagnostic delays for this rare immune disorder.

Area of Science:

  • Pediatric immunology
  • Computational diagnostics
  • Machine learning in healthcare

Background:

  • Common Variable Immunodeficiency (CVID) presents with recurrent sinopulmonary infections, often leading to diagnostic delays in children due to overlapping symptoms.
  • A significant diagnostic lag, averaging 10 years, highlights the urgent need for improved early identification strategies for pediatric CVID.

Purpose of the Study:

  • To develop and validate machine learning models for identifying a distinct clinical signature of CVID in pediatric patients.
  • To enable earlier and more accurate diagnosis of Common Variable Immunodeficiency in children.

Main Methods:

  • Utilized a cohort of 112 individuals with CVID and 627 controls, excluding those with other infection-associated conditions.
  • Trained and validated three supervised machine learning classifiers, including an Extreme Gradient Boosting (XGBoost) model, on patient-level clinical metrics.
  • Validated findings with a high-complexity control cohort and a logistic regression approach.

Main Results:

  • The Extreme Gradient Boosting (XGBoost) model demonstrated strong predictive performance (F1 score 0.77) for CVID diagnosis up to 10 years prior.
  • Key predictive features included chest radiograph counts, antibiotic prescription frequency, and the incidence of common infections.
  • The model correctly classified 21 of 29 CVID cases and 179 of 183 non-CVID patients, indicating high accuracy.

Conclusions:

  • A distinct clinical signature for pediatric CVID was identified, enabling earlier detection even with frequent infections in the control group.
  • Machine learning techniques offer a promising avenue for reducing diagnostic delays and improving outcomes for children with CVID.
Abstract